title: Both dynorphin A(1-17) and [Des-Tyr1]dynorphin A(2-17) inhibit adenylyl cyclase activity in rat caudate putamen.
abstract: In this study, the ability of a series of dynorphin peptides to inhibit adenylyl cyclase (AC) activity was determined. The endogenous ligand of the kappa opioid receptor, dynorphin A(l-17) (Dyn A(l-17)), produced a significant concentration-dependent inhibition of AC activity in membranes prepared from the caudate putamen (CPu) of naive Fischer 344 rats. The opioid receptor antagonist, naloxone (10(-5)M), which is predominantly mu opioid receptor directed, but with modest kappa and delta receptor activity, partially blocked this inhibition. Nor-Binaltorphimine (10(-5)M), the selective kappa receptor antagonist, also blocked the effect of Dyn A(l-17), but to a lesser degree. [Des-Tyr1]Dyn A(2-17), a major nonopioid biotransformation product of Dyn A(l-17) with known biological activities, also inhibited AC in rat CPu membranes. Dyn A(l-13) inhibited AC, as did its major opioid biotransformation product, Dyn A(l-12). One of the major nonopioid biotransformation products of Dyn A(l-13), Dyn A(4-12), showed no activity. Dyn A(2-12), another nonopioid product of Dyn A(l-13), showed limited activity. Dyn A(l-6), a minor biotransformation product of both Dyn A(l-17) and Dyn A(l-13), also inhibited AC activity. These findings suggest that, in rat CPu membranes, the inhibition of AC activity by Dyn A(l-17) is mediated in part by kappa and mu opioid receptors. In addition, Dyn A(2-17), and to a lesser extent Dyn A(2-12), may bind to a yet unidentified site that is also coupled to the AC enzyme in rat CPU.
authors.affiliation: Laboratory for the Biology of Addictive Diseases, The Rockefeller University, New York, USA.
authors.forename: L H
authors.initials: LH
authors.lastname: Claye
authors.forename: E M
authors.initials: EM
authors.lastname: Unterwald
authors.forename: A
authors.initials: A
authors.lastname: Ho
authors.forename: M J
authors.initials: MJ
authors.lastname: Kreek
mesh_terms: D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D002421:Caudate Nucleus / Q000201:enzymology*; D004399:Dynorphins / Q000494:pharmacology*; D008297:Male; D009270:Naloxone / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D011699:Putamen / Q000201:enzymology*; D051381:Rats; D011916:Rats, Inbred F344; D016194:Receptors, N-Methyl-D-Aspartate / Q000502:physiology
chemical_list: D000067956:Adenylyl Cyclase Inhibitors; D010446:Peptide Fragments; D016194:Receptors, N-Methyl-D-Aspartate; D009270:Naloxone; D004399:Dynorphins